Cargando…

Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents

Objectives: Aripiprazole modulates dopaminergic and serotonergic pathways that may play a role in the pathogenesis of Tourette's disorder (TD). This trial evaluated the efficacy and safety of oral aripiprazole in the suppression of tics in children and adolescents with TD. Methods: This phase 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sallee, Floyd, Kohegyi, Eva, Zhao, Joan, McQuade, Robert, Cox, Kevin, Sanchez, Raymond, van Beek, Alet, Nyilas, Margaretta, Carson, William, Kurlan, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689110/ https://www.ncbi.nlm.nih.gov/pubmed/28686474 http://dx.doi.org/10.1089/cap.2016.0026

Ejemplares similares

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
por: Fleischhacker, W. Wolfgang, et al.
Publicado: (2016)

Complex obsessive compulsive and impulsive symptoms in Tourette’s syndrome
por: Palumbo, Donna, et al.
Publicado: (2007)

Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study
por: Muzina, D J, et al.
Publicado: (2008)

Case report on Tourette syndrome treated successfully with aripiprazole
por: BHATIA, MS, et al.
Publicado: (2014)

Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder: Results of 2 Phase 3, Randomized, Double-blind, Multicenter, Placebo-Controlled Trials
por: Adler, Lenard A., et al.
Publicado: (2022)

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders
por: Cox, Joanna H, et al.
Publicado: (2016)

Temporal Course of the Tourette Syndrome Clinical Triad
por: Shprecher, David R., et al.
Publicado: (2014)

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia
por: Kane, John M., et al.
Publicado: (2013)

Discovery research and development history of the dopamine D(2) receptor partial agonists, aripiprazole and brexpiprazole
por: Kikuchi, Tetsuro, et al.
Publicado: (2021)

Successful Treatment of Tourette Syndrome With a Combination of Guanfacine and Aripiprazole: A Case Series
por: George, Tikku, et al.
Publicado: (2023)

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
por: Berman, Robert M, et al.
Publicado: (2011)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis
por: Kane, John M., et al.
Publicado: (2015)

Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study
por: Peters-Strickland, Timothy, et al.
Publicado: (2015)

Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome
por: Tao, Deshuang, et al.
Publicado: (2019)

Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome
por: Gerasch, Sarah, et al.
Publicado: (2016)

Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy
por: Nelson, J. Craig, et al.
Publicado: (2014)

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores
por: Ismail, Zahinoor, et al.
Publicado: (2017)

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration
por: Raoufinia, Arash, et al.
Publicado: (2017)

The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies
por: Weiss, Catherine, et al.
Publicado: (2018)

Aripiprazole Selectively Reduces Motor Tics in a Young Animal Model for Tourette’s Syndrome and Comorbid Attention Deficit and Hyperactivity Disorder
por: Rizzo, Francesca, et al.
Publicado: (2018)

Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study
por: Ichikawa, Hironobu, et al.
Publicado: (2016)

Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania
por: Ostacher, Michael J, et al.
Publicado: (2015)

ARTS AND CREATIVITY AND THEIR IMPACT ON HEALTH AND WELL-BEING: A SYSTEMATIC REVIEW OF THE EVIDENCE
por: O'Sullivan, Roger, et al.
Publicado: (2022)

Tourette syndrome and learning disabilities
por: Burd, Larry, et al.
Publicado: (2005)

Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug
por: Rohde, Morten, et al.
Publicado: (2014)

Metabolic effects of adding Topiramate on Aripiprazole in bipolar patients aged between 6-18 years, a randomized, double-blind, placebo-controlled trial
por: Arman, Soroor, et al.
Publicado: (2022)

Osteoarthritis of the Knee
por: McQuade, Jean
Publicado: (2015)

Compulsory Health Insurance
por: McQuade, Jerry
Publicado: (1920)

Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin
por: Kawai, Akito, et al.
Publicado: (2022)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Are there distinct subtypes in Tourette syndrome? Pure-Tourette syndrome versus Tourette syndrome-plus, and simple versus complex tics
por: Eapen, Valsamma, et al.
Publicado: (2015)

Aripiprazole cardiosafety: Is it overestimated?
por: Naguy, Ahmed
Publicado: (2016)

Aripiprazole-induced priapism
por: Trivedi, Satya K., et al.
Publicado: (2016)

Digit ratio links prenatal hormone exposure with adult lung function
por: McQuade, Denise Brooks
Publicado: (2014)

Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers
por: Sallee, Floyd R.
Publicado: (2015)

Genome-wide association study of Tourette Syndrome
por: Scharf, Jeremiah M., et al.
Publicado: (2012)

Tics and Tourette’s syndrome
por: Mittal, Shivam Om
Publicado: (2020)

Tourette disorder and sleep
por: Blaty, Justin L., et al.
Publicado: (2022)

Advances in Tourette’s syndrome
por: Robertson, Neil P.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ji6p6s1047fmc7av3222gcksin